"With silicone breast implants back on the market, a debate over follow-up care is roiling the plastic surgery community, even as more women are choosing to have their breasts surgically enlarged.
When the Food and Drug Administration decided last November to again allow the use of silicone for breast augmentation, it did so provided that manufacturers instruct doctors to advise patients they will need biannual M.R.I.’s to check for ruptures and should remove the implants if a rupture is detected.
But some surgeons are criticizing the recommendations, saying they are bureaucratic and unscientific and that they interfere with their ability to tailor diagnosis and treatment to each patient. Some said they would not recommend the M.R.I.’s, while others said they would follow the recommendations, albeit unenthusiastically."
For the full text, click here.
No comments:
Post a Comment